Zhibo Shen
First Affiliated Hospital of Zhengzhou University(CN)
Publications by Year
Research Areas
RNA modifications and cancer, Cancer Immunotherapy and Biomarkers, Cancer-related molecular mechanisms research, Ferroptosis and cancer prognosis, Immune cells in cancer
Most-Cited Works
- → Macrophage-derived CCL22 promotes an immunosuppressive tumor microenvironment via IL-8 in malignant pleural effusion(2019)177 cited
- → IL6 derived from cancer-associated fibroblasts promotes chemoresistance via CXCR7 in esophageal squamous cell carcinoma(2017)167 cited
- → Hypoxia-induced GBE1 expression promotes tumor progression through metabolic reprogramming in lung adenocarcinoma(2020)112 cited
- → Long noncoding RNA MALAT1 promotes malignant development of esophageal squamous cell carcinoma by targeting β-cateninviaEzh2(2016)97 cited
- → MiR-760 suppresses human colorectal cancer growth by targeting BATF3/AP-1/cyclinD1 signaling(2018)90 cited
- → Large-scale analysis reveals the specific clinical and immune features of B7-H3 in glioma(2018)88 cited
- → COL1A1 is a prognostic biomarker and correlated with immune infiltrates in lung cancer(2021)84 cited
- → Lung adenocarcinoma-intrinsic GBE1 signaling inhibits anti-tumor immunity(2019)81 cited
- → Untargeted Metabolomics Analysis of Esophageal Squamous Cell Carcinoma Discovers Dysregulated Metabolic Pathways and Potential Diagnostic Biomarkers(2020)56 cited
- → Over-Expression and Prognostic Significance of FN1, Correlating With Immune Infiltrates in Thyroid Cancer(2022)51 cited